FDA MUST PUBLISH PATENT EXPIRATION DATES AS SUBMITTED BY NDA HOLDERS, MERCK MAINTAINS IN SUIT CHALLENGING FDA IMPLEMENTATION OF GATT PATENT PROVISIONS
Executive Summary
FDA cannot refuse to publish patent expiration dates as submitted by sponsors in the "Orange Book," Merck maintains in a suit filed against FDA and the Patent & Trademark Office July 27 in Alexandria, Va. federal court.